eRaDicate | Innovative ligands for nuclear receptors to eradicate cancer relapse.
01-01-2024
-31-12-2027
Show more information
Organisation
KARL LANDSTEINER PRIVATUNIVERSITAT FUR GESUNDHEITSWISSENSCHAFTEN GMBH